![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Concise Commentary: Bloating in IBS: Can We Burst the Bubble?
-
Article
Antibiotics for Dyspepsia: Hp, SIBO, IMO, or Something Else?
-
Article
Open AccessA randomized controlled trial of a proactive analgesic protocol demonstrates reduced opioid use among hospitalized adults with inflammatory bowel disease
Most hospitalized patients with inflammatory bowel disease (IBD) experience pain. Despite the known risks associated with opioids in IBD including risk for misuse, overdose, infection, readmission, and even de...
-
Chapter
The Role of the Microbiome in Inflammatory Bowel Disease
Changes in the gut microbiome have long been thought to play a role in inflammatory bowel disease (IBD), including both Crohn’s disease (CD) and ulcerative colitis (UC). While early studies did not identify sp...
-
Article
Open AccessEndotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study
Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mamm...
-
Article
Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization
Most patients with IBD experience pain, especially during acute disease exacerbations. Opioid use continues to be more prevalent in IBD than any other chronic gastrointestinal condition, and the majority of IB...
-
Article
Open AccessComparing the rates of methane production in patients with and without appendectomy: results from a large-scale cohort
There is no clear study identifying the microbiome of the appendix. However, in other diverticular conditions, such as diverticulosis, methanogens appear important. We investigated whether patients who had und...